| Name | Date Acquired | How Acquired | Date Sold | Purchaser Name | Gross Sales Price | Basis | Basis Method | Sales Expenses | Total (net) | Accumulated Depreciation |
|---|---|---|---|---|---|---|---|---|---|---|
| FNMIX | 2014-01 | Purchased | 2014-02 | 25,096 | 27,338 | -2,242 | ||||
| FNMIX | 2012-01 | Purchased | 2014-02 | 23,824 | 25,952 | -2,128 | ||||
| MNK | 2013-07 | Purchased | 2014-07 | 191,999 | 105,455 | 86,544 | ||||
| FNMIX | 2012-01 | Purchased | 2014-02 | 334,993 | 335,204 | -211 | ||||
| Citibank bond settlement | 2008-01 | Purchased | 2014-09 | 19,701 | 19,701 | |||||
| Fidelity capial gain distributions | 2013-01 | Purchased | 2014-12 | 8,765 | 8,765 |
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| ChevronTexaco | 1,153,594 | 2,849,372 |
| Minerals Technology | 69,450 | |
| Met Life | 314,476 | 540,900 |
| Pfizer | 645,599 | 2,158,695 |
| Category/ Item | Listed at Cost or FMV | Book Value | End of Year Fair Market Value |
|---|---|---|---|
| Ivy Science & Technology | 117,587 | 190,409 | |
| Vanguard Energy | 121,808 | 104,120 | |
| Wasatch Emerging Markets Small Cap | 103,048 | 110,290 |
| Description | Amount |
|---|---|
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| NFC Investment Adv | 148,737 | |||
| TD Bank-fee charge for checks | 6 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| Foreign taxes | 399 | |||
| Federal tax | 16,311 |